ScholarLens Back to search
2012•Guide of China MedicineRequires access

The Clinical Observation of Rivaroxaban to Prevent Deep Venous Thrombosis Following Total Hip Arthroplasty

Long De-sheng

Open publisher page 0 citations

Abstract

Objective To observe the clinical effects of rivaroxaban against DVT after total hiparthroplasty.Methods Totally 83 THA patients were random divided into two groups.Rivaroxaban were used on group A(42 cases) for 14 days.LMWH were used on group B(41 cases) for 14 days.Results There was no intraoperative bleeding between the two groups.The incidence rate of deep vein thrombosis in the rivaroxaban treatment group was 4.76%(2 cases).The incidence rate of deep veinthrombosis in the LMWH treatment group was 4.87%(2 cases).There was no statistics differences in DVT prevention and between the two groups(P0.05).Conclusion Rivaroxaban had good efficacy on DVT prevention after total hip arthroplasty.Rivaroxaban had similar effects and security to LMWH on DVT prevention after THA.

About this research paper

What this paper is about

Objective To observe the clinical effects of rivaroxaban against DVT after total hiparthroplasty.Methods Totally 83 THA patients were random divided into two groups.Rivaroxaban were used on group A(42 cases) for 14 days.LMWH were used on group B(41 cases) for 14 days.Results There was no intraoperative bleeding between the two groups.The incidence rate of deep vein thrombosis in the rivaroxaban treatment group was 4.76%(2 cases).The incidence rate of deep veinthrombosis in the LMWH treatment group was 4.87%(2 cases).There was no statistics differences in DVT prevention and between the two groups(P0.05).Conclusion Rivaroxaban had good efficacy on DVT prevention after total hip arthroplasty.Rivaroxaban had similar effects and security to LMWH on DVT prevention after THA.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effects of rivaroxaban against DVT after total hiparthroplasty.Methods Totally 83 THA patients were random divided into two groups.Rivaroxaban were used on group A(42 cases) for 14 days.LMWH were used on group B(41 cases) for 14 days.Results There was no intraoperative bleeding between the two groups.The incidence rate of deep vein thrombosis in the rivaroxaban treatment group was 4.76%(2 cases).The incidence rate of deep veinthrombosis in the LMWH treatment group was 4.87%(2 cases).There was no statistics differences in DVT prevention and between the two groups(P0.05).Conclusion Rivaroxaban had good efficacy on DVT prevention after total hip arthroplasty.Rivaroxaban had similar effects and security to LMWH on DVT prevention after THA.

Key concepts: Rivaroxaban, Medicine, Deep vein, Thrombosis, Surgery, Incidence (geometry), Total hip arthroplasty, Venous thrombosis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Clinical Observation of Rivaroxaban to Prevent Deep Venous Thrombosis Following Total Hip Arthroplasty — Research Paper | ScholarLens